Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA

ABSTRACT:

SUBMITTER: Lichtman-Mikol S 

PROVIDER: S-EPMC13646922 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature